R. J. Steenbakkers, K. E. Deurloo, P. J. Nowak, J. V. Lebesque, M. van Herk, C. R. Rasch, “Reduction of the dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate,” International Journal of Radiation Oncology Biology Physics, Vol. 57, No. 5, 2003, pp. 1269-79. http://dx.doi.org/10.1016/S0360-3016(03)01446-9

has been cited by the following article:

• TITLE: Three-Tesla Magnetic Resonance and Computed Tomography Imaging in Three-Dimensional Conformal Radiotherapy for Localized Prostate Cancer

  AUTHORS: Gianluca Ingrosso, Alessandra Carosi, Elisabetta Ponti, Pierluigi Bove, Riccardo Santoni

  KEYWORDS: Prostate Cancer, 3 Tesla Magnetic Resonance, Computed Tomography, Conformal Radiotherapy

  JOURNAL NAME: Open Journal of Radiology, Vol.1 No.1, September 28, 2011

  ABSTRACT: Aims and background: we evaluate CT-3Tesla MRI fusion in conformal radiotherapy for localized prostate cancer.Methods: 18 consecutive patients underwent a 3T MRI scan under radiotherapy planning conditions, after the CT scan. Bowel and bladder preparation were prescribed. CT and MR images were automatically fused; prostate and seminal vesicles were contoured on CT and on MRI, organs at risk were defined on CT-MRI fusion. Late rectal and sexual toxicity, differences in target volume between MRI and CT and differences in rectal and penile bulb dose distribution based on CT only or on CT-MRI fusion were evaluated.Results: one patient experienced a late rectal toxicity; no patient had sexual toxicity. The difference between the mean MRI and CT target volumes was statistically significant (p = 0.0001 paired Student's t-test). The dose-volume histogram (DVH) analysis shows a significant reduction of the dose received by the rectum and the penile bulb in MRI-plans compared to CT-plans.Conclusions: 3 Tesla MRI scan under radiotherapy planning conditions along with bowel preparation significantly improves the definition of the target volume sparing normal tissue irradiation.